GBA-associated PD: chances and obstacles for targeted treatment strategies
Publikation: Beitrag in Fachzeitschrift › Übersichtsartikel (Review) › Eingeladen › Begutachtung
Beitragende
Abstract
Given the clear role of GBA in the pathogenesis of Parkinson's disease (PD) and its impact on phenotypical characteristics, this review provides an overview of the current knowledge of GBA-associated PD with a special focus on clinical trajectories and the underlying pathological mechanisms. Importantly, differences and characteristics based on mutation severity are recognized, and current as well as potential future treatment options are discussed. These findings will inform future strategies for patient stratification and cohort enrichment as well as suitable outcome measures when designing clinical trials.
Details
Originalsprache | Englisch |
---|---|
Seiten (von - bis) | 1219-1233 |
Seitenumfang | 15 |
Fachzeitschrift | Journal of neural transmission |
Jahrgang | 129 |
Ausgabenummer | 9 |
Publikationsstatus | Veröffentlicht - Sept. 2022 |
Peer-Review-Status | Ja |
Externe IDs
PubMedCentral | PMC9463270 |
---|---|
Scopus | 85131102002 |
ORCID | /0000-0002-2387-526X/work/150328949 |
Schlagworte
Schlagwörter
- Cohort Studies, Glucosylceramidase/genetics, Humans, Mutation, Parkinson Disease/drug therapy